KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Inventory Average (2016 - 2026)

Supernus Pharmaceuticals has reported Inventory Average over the past 14 years, most recently at $80.9 million for Q4 2025.

  • Quarterly Inventory Average rose 36.79% to $80.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.9 million through Dec 2025, up 36.79% year-over-year, with the annual reading at $68.3 million for FY2025, 3.78% up from the prior year.
  • Inventory Average was $80.9 million for Q4 2025 at Supernus Pharmaceuticals, up from $61.7 million in the prior quarter.
  • Over five years, Inventory Average peaked at $91.3 million in Q1 2023 and troughed at $46.7 million in Q2 2025.
  • The 5-year median for Inventory Average is $74.7 million (2021), against an average of $72.3 million.
  • Year-over-year, Inventory Average skyrocketed 93.06% in 2021 and then tumbled 34.76% in 2025.
  • A 5-year view of Inventory Average shows it stood at $73.1 million in 2021, then grew by 19.57% to $87.4 million in 2022, then dropped by 7.91% to $80.4 million in 2023, then dropped by 26.49% to $59.1 million in 2024, then skyrocketed by 36.79% to $80.9 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Inventory Average are $80.9 million (Q4 2025), $61.7 million (Q3 2025), and $46.7 million (Q2 2025).